Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.
Nabholtz JM, Senn HJ, Bezwoda WR, Melnychuk D, Deschênes L, Douma J, Vandenberg TA, Rapoport B, Rosso R, Trillet-Lenoir V, Drbal J, Molino A, Nortier JW, Richel DJ, Nagykalnai T, Siedlecki P, Wilking N, Genot JY, Hupperets PS, Pannuti F, Skarlos D, Tomiak EM, Murawsky M, Alakl M, Aapro M, et al. Nabholtz JM, et al. Among authors: skarlos d. J Clin Oncol. 1999 May;17(5):1413-24. doi: 10.1200/JCO.1999.17.5.1413. J Clin Oncol. 1999. PMID: 10334526 Clinical Trial.
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Papadimitriou C, Dafni U, Bafaloukos D, Skarlos D, Moulopoulos LA, Razis E, Kalofonos HP, Aravantinos G, Briassoulis E, Papakostas P, Abela K, Gogas E, Kosmidis P, Pavlidis N, Dimopoulos MA. Fountzilas G, et al. Among authors: skarlos d. J Clin Oncol. 2001 Apr 15;19(8):2232-9. doi: 10.1200/JCO.2001.19.8.2232. J Clin Oncol. 2001. PMID: 11304776 Clinical Trial.
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group.
Kosmidis P, Mylonakis N, Fountzilas G, Pavlidis N, Samantas E, Karabelis A, Kattis K, Skarlos D. Kosmidis P, et al. Among authors: skarlos d. Ann Oncol. 1996 Jul;7(5):517-20. doi: 10.1093/oxfordjournals.annonc.a010642. Ann Oncol. 1996. PMID: 8839908 Free article. Clinical Trial.
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Aravantinos G, Fountzilas G, Kosmidis P, Dimopoulos MA, Stathopoulos GP, Pavlidis N, Bafaloukos D, Papadimitriou C, Karpathios S, Georgoulias V, Papakostas P, Kalofonos HP, Grimani E, Skarlos DV; Hellenic Cooperative Oncology Group. Aravantinos G, et al. Among authors: skarlos dv. Ann Oncol. 2005 Jul;16(7):1116-22. doi: 10.1093/annonc/mdi223. Epub 2005 May 31. Ann Oncol. 2005. PMID: 15928071 Free article. Clinical Trial.
A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials.
Kosmidis P, Mylonakis N, Skarlos DV, Samantas E, Beer M, Theocharis D, Zachariadis E, Gioti A, Papadakis E, Poulakis N, et al. Kosmidis P, et al. Among authors: skarlos dv. Ann Oncol. 1994 Feb;5(2):159-62. doi: 10.1093/oxfordjournals.annonc.a058769. Ann Oncol. 1994. PMID: 8186159 Free article. Clinical Trial.
197 results